Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

NBP

NASDAQ

NovaBridge Biosciences (NBP)

1.30 USD −1.52% vs prior close Oct 13, 2026
NovaBridge Biosciences price graph
35 sessions
2.0 1.2 24 Aug 13 Oct

The line runs 1.88 USD on 24 August through 1.30 USD on 13 October, on a scale from 1.2 to 2.0. Days the market did not trade hold the previous close, flat.

EPS, diluted, year to Dec 2025
−0.21 USD
52-week range
1.30 USD – 5 USD
Avg volume
40.6K

as of Oct 13, 2026

Have NovaBridge Biosciences (NBP) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, NovaBridge Biosciences insiders reported 3 open-market sales and 2 purchases (SEC Form 4).

Form 4, 90 days to 22 Nov 2026, newest reported trade 18 Nov 2026

2buys
3sells
$2Knet sold
4other filings
Have NovaBridge Biosciences (NBP) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
18 Nov 2026Hagler Mark ArnoldChief Commercial OfficerBuy184,00070K USD
17 Nov 2026Hagler Mark ArnoldChief Commercial OfficerBuy46,00016K USD
18 Sep 2026Dennis Phillip AndrewChief Medical OfficerSell8,2096K USD
09 Sep 2026Cao Sean WuxiongChief Bus. Development OfficerSell107,97880K USD
31 Aug 2026Xu Cong ClaireEVP, Clinical DevelopmentSell3,2823K USD
Bought2 open-market purchases230,000$86K
Sold3 open-market sales119,469$88K
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have NovaBridge Biosciences (NBP) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
15 Oct 2026Woo Ian YingDirectorOption exercise13,271
17 Sep 2026Dennis Phillip AndrewChief Medical OfficerOption exercise23,695
03 Sep 2026Cao Sean WuxiongChief Bus. Development OfficerOption exercise339,372
30 Aug 2026Xu Cong ClaireEVP, Clinical DevelopmentOption exercise9,382

Which funds hold NovaBridge Biosciences (NBP)?

4 of the 45 institutional funds we track reported a NovaBridge Biosciences position for the quarter ended 30 Sep 2026 — a combined 4.7M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold NovaBridge Biosciences (NBP)?
FundPositionSharesValueShares q/q
Citadel AdvisorsAdded1,381,5161.9M USD+121.8%
Two Sigma InvestmentsHeld (±25%)874,2501.2M USD+2.7%
Marshall WaceTrimmed727,345989K USD−41.0%
Renaissance TechnologiesTrimmed485,191662K USD−36.0%

What has been filed or recorded for NovaBridge Biosciences (NBP)?

The filings we hold for NovaBridge Biosciences, newest first: 3 fails-to-deliver days and 4 reported financial figures, the latest dated 30 Oct 2026.

What has been filed or recorded for NovaBridge Biosciences (NBP)?
And
30 Oct 2026Fails to deliverShares failed to deliver44,124 shares53K USD notional · 0.017% of shares out
23 Oct 2026Fails to deliverShares failed to deliver26,125 shares35K USD notional · 0.010% of shares out
07 Oct 2026Fails to deliverShares failed to deliver100 shares140 USD notional · <0.001% of shares out
31 Dec 2025FinancialsNet income−46.3M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.21 USDfiscal year
31 Dec 2025FinancialsTotal assets260.5M USDat period end
31 Dec 2025FinancialsTotal equity230.9M USDat period end

What do people ask about NovaBridge Biosciences (NBP)?

From live data
What did NovaBridge Biosciences shares close at?1.30

NovaBridge Biosciences closed at 1.30 USD on 13 Oct 2026, down 1.52% on the close before. That is the end-of-day price from Finazon, not a live quote.

Have NovaBridge Biosciences insiders bought or sold shares recently?3 sales

In the 90 days to 22 Nov 2026, NovaBridge Biosciences insiders reported 3 open-market sales and 2 purchases (SEC Form 4). A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own NovaBridge Biosciences?4 of 45

4 of the 45 funds we track reported a NovaBridge Biosciences position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Two Sigma Investments and Marshall Wace. See Funds

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 31 Dec 2025